Enbrel and Weight decrease neonatal for Boys aged 0-1 (a phase IV clinical study of FDA data)

Summary:

Weight decrease neonatal is found for boys aged 0-1 who take Enbrel (etanercept). This study is created by eHealthMe based on reports of 159 boys aged 0-1 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Enbrel when people have Weight decrease neonatal
Top conditions
Top co-used drugs
Top other side effects

On Apr, 13, 2026

159 boys aged 0-1 reported to have side effects when taking Enbrel.
Among them, 5 people (3.14%) have Weight decrease neonatal

What is Enbrel?

Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 664,677 Enbrel users. Check the latest studies of Enbrel.

What is Weight decrease neonatal?

Weight decrease neonatal is found to be associated with 26 drugs and 114 conditions by eHealthMe. Check the latest studies of Weight decrease neonatal.

Number of reports submitted per year:

Could Enbrel cause Weight decrease neonatal in boys aged 0-1?

Severity of Weight decrease neonatal

n/a

How people recovered from Weight decrease neonatal

n/a

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Methyldopa: 3 people, 60.00%

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Urinary Tract Infection: 3 people, 60.00%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 3 people, 60.00%
Dehydration (dryness resulting from the removal of water): 3 people, 60.00%
Bacteraemia (presence of bacteria in the blood): 3 people, 60.00%
Premature Baby: 2 people, 40.00%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 2 people, 40.00%
Jaundice Neonatal (yellowing of skin in neonate): 2 people, 40.00%
Blood Glucose Decreased: 2 people, 40.00%

* Approximation only. Some reports may have incomplete information.

Do you take Enbrel and have Weight decrease neonatal?

- Check whether Weight decrease neonatal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Enbrel and Weight decrease neonatal

How the study uses the data?

The study is based on (applicable) gender, age, etanercept (the active ingredients of Enbrel) and Enbrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.